Integrin α6A splice variant regulates proliferation and the Wnt/β-catenin pathway in human colorectal cancer cells

Carcinogenesis

Volumn 35, Issue 6, 2014, Pages 1217-1227

  Groulx, Jean François ^a   Giroux, Véronique ^b   Beauséjour, Marco ^a   Boudjadi, Salah ^a   Basora, Nuria ^a   Carrier, Julie C ^b   Beaulieu, Jean François ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6 INTEGRIN; ALPHA6BETA4 INTEGRIN; BETA CATENIN; SHORT HAIRPIN RNA; DISHEVELLED PROTEINS; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; CACO 2 CELL LINE; CANCER CELL; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENETIC VARIABILITY; HT 29 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR XENOGRAFT; UPREGULATION; WNT SIGNALING PATHWAY; ALTERNATIVE RNA SPLICING; ANIMAL; COLORECTAL TUMOR; DISEASE MODEL; DRUG ANTAGONISM; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; INTRACELLULAR SPACE; METABOLISM; MOUSE; PATHOLOGY; PROTEIN SUBUNIT; PROTEIN TRANSPORT; TUMOR CELL LINE; TUMOR VOLUME; XENOGRAFT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALTERNATIVE SPLICING; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GLYCOGEN SYNTHASE KINASE 3; HETEROGRAFTS; HUMANS; INTEGRIN ALPHA6; INTRACELLULAR SPACE; MICE; PHOSPHOPROTEINS; PROTEIN SUBUNITS; PROTEIN TRANSPORT; TUMOR BURDEN; WNT SIGNALING PATHWAY;

EID: 84899933287     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgu006     Document Type: Article

References (50)

1. Margadant, C. et al. (2011) Mechanisms of integrin activation and trafficking. Curr. Opin. Cell Biol., 23, 607-614.
2. de Melker, A.A. et al. (1999) Integrins: alternative splicing as a mechanism to regulate ligand binding and integrin signaling events. Bioessays, 21, 499-509.
3. Hynes, R.O. (2002) Integrins: bidirectional, allosteric signaling machines. Cell, 110, 673-687.
4. Giancotti, F.G. (2003) A structural view of integrin activation and signaling. Dev. Cell, 4, 149-151.
5. Siegel, R. et al. (2012) Cancer statistics, 2012. CA Cancer J. Clin., 62, 10-29.
6. Guo, W. et al. (2004) Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol., 5, 816-826.
7. Beaulieu, J.F. (2010) Integrin α6β4 in colorectal cancer. World J. Gastrointest. Pathophysiol., 1, 3-11.
8. Wang, S. et al. (2009) Integrin-linked kinase: a multi-functional regulator modulating extracellular pressure-stimulated cancer cell adhesion through focal adhesion kinase and AKT. Cell. Oncol., 31, 273-289.
9. Mercurio, A.M. et al. (2001) Towards a mechanistic understanding of tumor invasion-lessons from the alpha6beta 4 integrin. Semin. Cancer Biol., 11, 129-141.
10. Lee, E.C. et al. (1992) The integrin alpha 6 beta 4 is a laminin receptor. J. Cell Biol., 117, 671-678.
11. Basora, N. et al. (1999) Expression of functionally distinct variants of the beta(4)A integrin subunit in relation to the differentiation state in human intestinal cells. J. Biol. Chem., 274, 29819-29825.
12. Dydensborg, A.B. et al. (2009) Integrin alpha6Bbeta4 inhibits colon cancer cell proliferation and c-Myc activity. BMC Cancer, 9, 223.
13. Ni, H. et al. (2005) Upregulation of a functional form of the beta4 integrin subunit in colorectal cancers correlates with c-Myc expression. Oncogene, 24, 6820-6829.
14. Falcioni, R. et al. (1994) Integrin beta-4 expression in colorectal-cancer. Int. J. Oncol., 5, 573-578.
15. Chao, C. et al. (1996) A function for the integrin alpha6beta4 in the invasive properties of colorectal carcinoma cells. Cancer Res., 56, 4811-4819.
16. Shaw, L.M. (2001) Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion. Mol. Cell. Biol., 21, 5082-5093.
17. Mercurio, A.M. et al. (2004) Autocrine signaling in carcinoma: VEGF and the alpha6beta4 integrin. Semin. Cancer Biol., 14, 115-122.
18. Dans, M. et al. (2001) Tyrosine phosphorylation of the beta 4 integrin cytoplasmic domain mediates Shc signaling to extracellular signal-regulated kinase and antagonizes formation of hemidesmosomes. J. Biol. Chem., 276, 1494-1502.
19. Chen, M. et al. (2009) Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin. J. Biol. Chem., 284, 1484-1494.
20. Wang, Y. et al. (2011) Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb/E2F pathways to affect breast cancer metastasis. Mol. Cancer, 10, 84.
21. Lathia, J.D. et al. (2010) Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell, 6, 421-432.
22. Marchiò, S. et al. (2012) A complex of a6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. EMBO Mol. Med., 4, 1156-1175.
23. Wang, L. et al. (2011) Integrin a6(high) cell population functions as an initiator in tumorigenesis and relapse of human liposarcoma. Mol. Cancer Ther., 10, 2276-2286.
24. Desgrosellier, J.S. et al. (2010) Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer, 10, 9-22.
25. Friedrichs, K. et al. (1995) High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res., 55, 901-906.
26. Hogervorst, F. et al. (1993) Biochemical characterization and tissue distribution of the A and B variants of the integrin alpha 6 subunit. J. Cell Biol., 121, 179-191.
27. Tani, T.T. et al. (2001) PDZ interaction sites in integrin alpha subunits. T14853, TIP/GIPC binds to a type I recognition sequence in alpha 6A/alpha 5 and a novel sequence in alpha 6B. J. Biol. Chem., 276, 36535-36542.
28. Wixler, V. et al. (1999) Identification of novel interaction partners for the conserved membrane proximal region of alpha-integrin cytoplasmic domains. FEBS Lett., 445, 351-355.
29. Shaw, L.M. et al. (1995) The alpha 6A beta 1 and alpha 6B beta 1 integrin variants signal differences in the tyrosine phosphorylation of paxillin and other proteins. J. Biol. Chem., 270, 23648-23652.
30. Wei, J. et al. (1998) Regulation of mitogen-activated protein kinase activation by the cytoplasmic domain of the alpha6 integrin subunit. J. Biol. Chem., 273, 5903-5907.
31. Dydensborg, A.B. et al. (2009) Differential expression of the integrins alpha6Abeta4 and alpha6Bbeta4 along the crypt-villus axis in the human small intestine. Histochem. Cell Biol., 131, 531-536.
32. Groulx, J.F. et al. (2012) Autophagy is active in normal colon mucosa. Autophagy, 8, 893-902.
33. Dydensborg, A.B. et al. (2006) Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon. Am. J. Physiol. Gastrointest. Liver Physiol., 290, G1067-G1074.
34. Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, e45.
35. Segditsas, S. et al. (2006) Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene, 25, 7531-7537.
36. Van der Flier, L.G. et al. (2007) The intestinal Wnt/TCF signature. Gastroenterology, 132, 628-632.
37. Barker, N. et al. (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature, 449, 1003-1007.
38. Huang, W. et al. (2007) GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN. Oncogene, 26, 2471-2482.
39. Gao, C. et al. (2010) Dishevelled: the hub of Wnt signaling. Cell. Signal., 22, 717-727.
40. Miura, K. et al. (2012) Splice isoforms as therapeutic targets for colorectal cancer. Carcinogenesis, 33, 2311-2319.
41. Cariati, M. et al. (2008) Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int. J. Cancer, 122, 298-304.
42. Walter, B.M. et al. (2012) Mss4 protein is a regulator of stress response and apoptosis. Cell Death Dis., 3, e297.
43. Sakamuro, D. et al. (1996) BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nat. Genet., 14, 69-77.
44. Muders, M.H. et al. (2009) Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth. Clin. Cancer Res., 15, 4095-4103.
45. van der Flier, L.G. et al. (2009) Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu. Rev. Physiol., 71, 241-260.
46. Rowan, A.J. et al. (2000) APC mutations in sporadic colorectal tumors: a mutational "hotspot" and interdependence of the "two hits". Proc. Natl Acad. Sci. USA, 97, 3352-3357.
47. Korinek, V. et al. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science, 275, 1784-1787.
48. Yang, J. et al. (2006) Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells. J. Biol. Chem., 281, 17751-17757.
49. Gao, C. et al. (2010) Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation. Nat. Cell Biol., 12, 781-790.
50. Chan, D.W. et al. (2006) Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer. Gastroenterology, 131, 1218-1227.